| |
| |
|
| Insider
Information: |
Velleca Mark A. |
| Relationship: |
|
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
162,522 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$600,216 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
162,522 |
|
|
| Total
Value |
$600,216 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2023-08-08 |
116,000 |
2017-12-18 |
0 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2023-09-15 |
46,522 |
2022-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
88 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-04-16 |
4 |
AS |
$35.95 |
$269,971 |
D/D |
(7,500) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-04-16 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-05-15 |
4 |
AS |
$46.17 |
$347,064 |
D/D |
(7,500) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-05-15 |
4 |
OE |
$3.72 |
$27,900 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2022-12-16 |
4 |
A |
$1.50 |
$12,636 |
D/D |
8,424 |
21,157 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
|
– • – |
2023-06-16 |
4 |
A |
$2.10 |
$18,751 |
D/D |
8,929 |
41,314 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2019-01-17 |
4 |
OE |
$0.39 |
$3,510 |
D/D |
9,000 |
28,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-05-31 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2018-10-11 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
19,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-15 |
4 |
AS |
$19.43 |
$194,297 |
D/D |
(10,000) |
37,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-15 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
47,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-16 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
47,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-16 |
4 |
AS |
$19.20 |
$192,021 |
D/D |
(10,000) |
37,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-17 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
47,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
President and CEO |
• • – |
2020-12-17 |
4 |
AS |
$19.97 |
$199,668 |
D/D |
(10,000) |
37,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-01-19 |
4 |
AS |
$20.88 |
$208,781 |
D/D |
(10,000) |
37,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-01-19 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
47,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-01-20 |
4 |
AS |
$21.51 |
$215,107 |
D/D |
(10,000) |
37,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-01-21 |
4 |
AS |
$20.64 |
$206,400 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-01-21 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
51,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-17 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
51,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-17 |
4 |
AS |
$27.59 |
$276,433 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-18 |
4 |
AS |
$26.02 |
$260,152 |
D/D |
(10,000) |
41,000 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-02-18 |
4 |
OE |
$3.72 |
$37,200 |
D/D |
10,000 |
51,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2021-04-13 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
51,000 |
0 |
- |
|
88 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
